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Introduction.  PSSO-01, a Polish prospective multi-center project on rectal cancer, started in 2016 with participation on 
a voluntary basis. This study evaluates the early outcome of the surgical treatment of rectal cancer in Poland according 
to hospital volume. 
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Introduction
Every year, about 6,000 new cases of rectal cancer are recorded 
in Poland. Most of them require surgical treatment. Unfortu-
nately, we neither have a nationwide registry that allows us 
to determine the stage of the disease at the time of diagnosis, 
nor the ability to use prospective monitoring of the surgical 
outcomes with a nationwide scope. 
In 2016, the Polish Society of Surgical Oncology (PSSO) began 
collecting data on the surgical treatment of rectal cancer as part of 
a multi-center observational study (PSSO-01). One of the objectives 
of this project was to evaluate the early results of surgical treatment 
and to determine the proportion of patients who had a permanent 
intestinal stoma in long-term follow-up (up to 12 months after 
surgery). The purpose of this study was to provide basic data on 
the current surgical treatment of rectal cancer in Poland.
Material and methods
Study centers
The participation of the institutions in the research project PSSO-01 
was voluntary. The main criterion for the qualification of the centers 
was the possibility of monitoring postoperative complications wi-
thin a minimum of 30 days after surgery and long-term outcomes 
up to 12 months after surgery. At the beginning of the study (April 
2016), there were 7 registered centers. Others joined during the 
study. 17 out of 24 registered centers were active in the study. The 
activity of the centers during the study period is shown in figure 1. 
The recruitment process for the study has been described in detail 
and published previously [1]. Taking into account the number of 
patients enrolled in the study from each institution, the centers 
were divided into three categories: high volume (>50 operations 
per year), medium volume (25–50 operations per year), and low 
volume (<25 operations per year). Due to the COVID-19 pandemic 
and the temporary interruption of the normal work of the hospitals, 
the volume was calculated according to the following formula: 
(number of patients recruited until 31st March 2020 ÷ the time of 
the center’s activity [in months] to the date of 31st March 2021) × 12.
Population of the study 
The project of the study received the approval of the Bioethical 
Committee. During the study period, all patients with primary 
Material and methods.  The dataset derives from 17 clinical centers registered in the PSSO-01 study. From 2016 to 2020, the data 
of 1,607 patients were collected. Taking into account the number of patients enrolled in the study, the centers were divided into 
three categories: high volume, medium volume, and low volume. Nominal variables were compared between different categories 
of centers using the chi-square test. The STROBE guidelines were used to guarantee the reporting of this observational study.
Results.  More patients with metastatic disease were operated on in the low volume centers (p = 0.020). Neoadjuvant 
treatment was used in 35%, 52%, and 66% of patients operated on in low, medium, and high volume centers respectively 
(p < 0.001). Laparoscopic resection in medium volume centers was performed more often than in other centers (p < 0.001). 
The total rate of postoperative complications related to high, medium, and low centers was 22%, 26%, 18% (p = 0.044). 
One year following surgery, a stoma was present in 63% of patients. A defunctioning stoma following anterior resection 
was reversed in only 55% of patients. Anastomotic leakage was the main reason for a non-reversal diverting stoma. 
Conclusions.  The representation of low volume centers in the PSSO-01 study was understated. However, the outcomes 
may show the actual situation of surgical treatment of rectal cancer in high and medium volume centers in Poland.
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Figure 1. Activity of the centers in the study period
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rectal cancer (coded as C20, International Classification of Di-
sease-10) operated on at the research centers were registered. 
The following data were prospectively collected: 
• gender – distant metastases,
• concomitant diseases, 
• preoperative treatment, 
• technique and type of surgery, postoperative complica-
tions according to the Dindo-Clavien classification.
Because the main purpose of the PSSO-01 study focused 
on anastomotic leakage, wider data were collected only in the 
group of patients after anterior resection. 
Follow-up
The data of the presence of a stoma after anterior resection 
was prospectively collected within 12 months from the date 
of surgery. If a stoma at the evaluation points specified above 
was still present, the reasons for this has been described. The 
information on bowel restoration following Hartmann’s pro-
cedure was retrospectively collected. 
Statistical analysis
Missing data were not defaulted to negative, and denomina-
tors reflect only actual reported cases. Summary statistics were 
expressed by percentages for categorial variables. Nominal 
variables were compared between the three groups of patients 
operated on at different volume centers using the chi-square 
test. For all tests, the statistical significance was accepted at 
α = 0.05. All tests were two sided. The data were analyzed with 
SPSS version 19 for Windows (SPSS, Chicago, Illinois, USA).
Results
From April 2016 to December 2020, 1,607 patients undergo-
ing surgical treatment for rectal cancer were registered. The 
characteristics of the patients are shown in table I. More than 
half of the patients (53%; [95% confidence interval (CI): 49–57]) 
had concomitant diseases, the most common of which was 
hypertension 45% (95% CI: 43–47). Diabetes occurred in 15% 
(95% CI: 13–17) and ischemic heart disease in 14% (95% CI: 
12–16). The rate of patients with cancer spread (distant me-
tastases) at the time of the rectal cancer diagnosis was 13% 
[95% CI: 8–18]. Preoperative treatment of any kind was used in 
920 (57%) patients. During the operation, a stoma (permanent 
or temporary) was created in 890 (56%) patients. Taking into 
account the patients’ characteristics and their treatment, many 
statistically significant differences were found between the 
centers of different volumes – table II. 
More patients with advanced cancer (metastatic disease) 
were operated on in the low volume centers than in high 
volume centers: 18% vs. 11% respectively (p = 0.020; relative 
risk (RR): 1.61 [95% CI: 1.10–2.35]). There was also a difference 
in the proportion of patients with concomitant disorders (such 
as ischemic heart disease, hypertension, and diabetes) who 
were treated in different centers: high volume centers 48% 
vs. medium volume centers 57% (p = 0.005; RR 1.18 [95% CI: 
1.06–1.30] vs. low volume centers 60% (p = 0,006; RR 1.24 
[95% CI: 1.08–1.42]). Preoperative radiotherapy or chemo-
-radiotherapy was used in only 35% of patients operated on 
in low volume centers. This was less than in medium volume 
centers (p < 0.001;  RR 1.52 [95% CI: 1.23–1.87]) and in high 
volume centers (p < 0.001; RR 1.90  [95% CI: 1.55–2.32]). There 
were also differences in neoadjuvant treatment between high 
volume centers and medium volume centers: 66% and 52% 
respectively (p < 0.001; RR 1.25  [95% CI: 1.14–1.37]).
Surgical treatment
Emergency operations were performed more frequently in 
low volume centers than in medium and high volume centers 
(p < 0.001; RR 3.04 [95% CI: 1.67–5.53]). The rate of laparoscopic 
resection in medium volume centers was higher than in high vo-
lume centers (22% vs. 13%: p < 0.001; RR 1.70 [95% CI: 1.34–2.16)] 
Table I. Characteristic of the study group 
Patients
n (%)
volume of the study center:
• high (>50 operations per year)
• medium (25–50 operations per year)















• yes 846 (53)








































RTH – preoperative radiotherapy; CRT – preoperative chemo-radiotherapy; ASR 
– abdomino-sacralis resection; APR – abdomino-perineal resection; RA – anterior 
resection; LAR – low anterior resection (anastomosis ≤5 cm from the anal verge); 
HRTM – Hartmann’s procedure; PRCOL – proctocolectomy; LExc – local excision; 
STOM – colostomy; LPT – laparotomy; (*) – resection without laparotomy (for 
example: local excision) 
285
recorded in 359 (23%) patients. Most of them occurred in me-
dium volume centers (26%). The difference in proportion to 
high and low volume centers were 26% vs. 22% (p = 0.056; RR 
1.21 [95% CI: 1.00–1.47]) and 26% vs. 18% (p = 0.034; RR 1.42 
[95% CI: 1.02–1.98]) respectively. Taking into account only se-
rious postoperative complications (grade 3–5 according to the 
Dindo-Clavien Classification), the difference between medium 
and high volume centers was not significant (p = 0.110), but 
≥3 grade complications were higher in medium volume cen-
ters in relation to low volume centers (p = 0.016; RR 1.55 [95% 
CI: 1.13–2.12]). The rate of anastomotic leakage was similar in 
centers with different volume (8%, 10%, and 7%). Postoperative 
mortality was less than 1%. At the end of postoperative hospi-
talization, 707 (45%) patients had a permanent end-colostomy. 
Persistent stoma in long term observation 
The full follow-up covered 1,243 patients. Patients who had 
been lost from the follow-up (death or an observation pe-
and low volume centers (22% vs. 4%: p < 0.001; RR 5.53 [95% CI: 
2.72–12.05)]. There were no statistically significant differences 
between centers of different volume, taking into account the 
type of performed operations (p = 0.102). However, analysis of 
individual types of operations has shown that fewer low anterior 
resections in low volume centers were performed than in high 
and medium volume centers (13% vs. 21%: p = 0.018; RR 1.57 
[95% CI: 1.08–2.30]). Diverting stoma in resection with primary 
anastomosis was performed most often in high volume centers, 
and the least in low centers (p < 0.001) – table II.
The early outcomes of surgical treatment
Most palliative resections were performed in low volume centers 
(19%), and it was a statistically significant difference in propor-
tion to medium volume centers (p = 0.018; RR 1.61 [95% CI: 
1.11–2.32]) – table III. There were no differences in palliative re-
sections between high and medium volume centers (p = 0.075; 
RR 1,28 [95% CI: 0,97–1,68]). Postoperative complications was 
Table II. The surgical treatment and volume of the center
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preoperative RTH or CRT: 
• yes 559 (66%) 295 (52%) 66 (35%)
<0.001
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RTH – preoperative radiotherapy; CRT – preoperative chemo-radiotherapy; ASR – abdomino-sacralis resection; APR – abdomino-perineal resection; RA – anterior resection; 
LAR – low anterior resection (anastomosis ≤5 cm from the anal verge); HRTM – Hartmann’s procedure; PRCOL – proctocolectomy; LExc – local excision; STOM – colostomy; LPT – 
laparotomy;  (*) – resection without laparotomy (for example: local excision); (**) – percentage is related to the performed anastomoses
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riod less than 12 months) were excluded from the analysis of 
long-term outcomes. One year after the operation, a stoma 
was present in 777 (63%) patients. In 533 (43%) patients, it 
was connected with the primary type of surgery: abdomino-
-sacral resection / abdomino-perineal resection (ASR/APR; 
n = 341), proctocolectomy (PRCOL; n = 5), palliative Hartmann’s 
procedure (HRTM; n = 31), only colostomy (STOM; n = 133). 
In addition, in this group there were patients in whom primary 
anastomosis was a disconnection due to leakage, and a defi-
nitive end-colostomy was created (n = 23). In the remaining 
244 patients, a stoma was still present because no reversal of 
defunctioning stoma or no bowel restorative surgery after the 
radical Hartmann’s procedure was performed. The overall rate 
of bowel restorative surgery following the radical Hartmann’s 
procedure was only 2.4%. The defunctioning stoma following 
anterior resection (RA) or low anterior resection (LAR) was 
reversed in only 92 (55.4%) patients – figure 2. The reasons 
for delay in defunctioning stoma reversal is shown in table IV.
Discussion
Interim analysis of the secondary purpose of the PSSO-01 study 
was published previously [1]. This paper reports the final out-
comes based on the data of the 1607 patients enrolled in this 
study. Despite the large number of subjects enrolled on this 
trial, it should be kept in mind that the PSSO-01 project was not 
a registry of rectal cancer, and the results of this analysis should 
be treated with caution. Furthermore, the data collected during 
the study do not allow for detailed analysis of the reasons for 
the individual results of the observations. The purpose of the 
study was not to assess the quality of rectal cancer surgical 
treatment, but to present the current situation. 
Metastatic disease at the time of rectal cancer diagnosis 
(stage IV according to UICC) was found in 13% of the patients. 
Although some audit projects show similar data [2, 3], it must 
be assumed that this percentage is understated and does 
not reflect the actual situation. European population-based 
studies show that there are 22–26% of such cases [4] – table V. 
The actual proportion of patients in the advanced stages of 
the disease in Poland can reach 36–46% [5]. The low percen-
tage presented in the PSSO-01 study may be due to the small 
representation of low volume centers, where the majority of 
patients with advanced stages of the disease are operated on. 
Table III. The early outcomes of surgical treatment
Factor Total
n = 1607 
Volume of the center p value
High
n = 853 
Medium
n = 563 
Low






















































































(*) – percentage is related to the performed anastomoses; 1 – according to the Dindo-Clavien Classification; 2 – any surgical procedures with permanent stoma performed. 



















1 year after surgery
Figure 2. Persistent stoma in 1-year follow-up; analysis of 1243 patients 
(patients with incomplete data – excluded)
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In addition, some patients with multi-metastatic disease can 
not be treated surgically. 
Numerous European audit projects present important 
information on the effect of center volume on the outcomes 
of rectal cancer surgery. A population-based study provided 
in the Netherlands showed improved survival in cT4 rectal 
cancer patients treated in high volume centers, compared with 
low volume hospitals, but, after correction for neoadjuvant 
treatment, this difference was not statistically significant [6–8]. 
The criteria for dividing centers into high, medium, and small 
were similar to those in our study. In the Netherland’s study, the 
overall rate of neoadjuvant radiotherapy or chemo-radiothera-
py treatment was very high, and  there were small differences 
between low, medium, and high volume centers: 89%, 88%, 
and 90% respectively. Compared to this data, the information 
collected in the PSSO-01 study show much lower rate of pa-
tients treated preoperatively in different volume hospitals (66%, 
52%, and 35%). The reason for these differences are due to the 
fact that the PSSO-01 study patients with a tumor in the upper 
part of the rectum were enrolled. However, compared to data 
from Denmark, England, Norway, and Sweden, the overall rate 
of patients receiving radiotherapy is similar [4].
A laparoscopic resection of rectal cancer was performed 
less frequently than in other European countries. Schnitzbau-
er et al. has shown that the use of laparoscopy in Germany 
increased constantly from 12.3% to 48.1% between 2007 and 
2016 [9]. In the initial period of the PSSO 01 study (2016), the 
percentage of laparoscopic operations was only 9%, but it 
increased somewhat to 15% after 4 years. Although this is 
still a small rate, the upward trend is clearly visible and can be 
expected to reach the same level as other European countries 
in the coming years. Currently, the most laparoscopic resec-
tions are performed in medium volume centers (22%), and the 
least in low volume centers (4%). Other than that, data from 
the Dutch centers show that the most laparoscopic operations 
are performed in high volume centers (59.8%), but low volume 
centers perform 45.7% [7]. 
The total rate of restorative rectal resection (anterior resec-
tion or low anterior resection) was 53% (51–58% depending 
on the center’s volume). For Hartmann’s procedure (HRTM), 
this was 13% (11–17%), and abdomino-sacral resection / ab-
domino-perineal resection (ASR/APR) 21% (19–22%). The diffe-
rences between different volume centers were not statistically 
significant. The exception was for low anterior resection (LAR), 
which was performed less frequently in low volume centers 
than in high and medium volume centers. Data from Belgian 
Table IV. The reasons for delay in defunctioning stoma reversal (up to 12 
months)
No. of patients and 
percentage 
anastomotic leakage 17 (23.0)
cancer disease progression 9 (13.4)
stricture of anastomosis 2 (2.7)
disagreement to restorative operations 5 (6.8)
ileus of the bowel 2 (2.7)
other (*) 39 (52.7)
 (*) – adjuvant or palliative chemotherapy, the COVID-19 pandemic and other 
institutional burdens
Table V. Rectal cancer surgery in Europe 


























years of data 
collected
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radiotherapy 27% 41% 43% 51% 83% 50% 40% (^) 57%
laparoscopic 
approach ND ND ND ND 38% ND 28% 15%
received resectional 
surgery 68% 60% 66% 71% 95% 81% ND 89%
(*) – percentage is related to the whole study group; (^) – percentage is related to only UICC stage I–III, R0 resection and planned operation; ND – no data; 1 – The Dutch Surgical 
Colorectal Audit; 2 – Belgian multidisciplinary project on cancer of the rectum; 3 – Belgian Cancer Registry; 4 – InterMutualistic Agency database
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databases show a 59% rate of sphincter saving operations, 3% 
of HRTM and 17% of ASR [3]. A population-based study from 
the Netherlands (based on the Dutch Surgical Colorectal Audit 
– DSCA) presents statistically significant differences between 
different volume centers by taking into account the type of 
surgery: more sphincter saving procedures (LAR and HRTM 
account together) and low ASR in high volume centers [6]. The 
DSCA audit showed that the total ASR percentage was 30.5% 
[2], which is higher than in the PSSO-01 study. However, all this 
data is difficult to compare because the type of resection, such 
as ASR/APR or LAR, is mainly determined by the location of the 
tumor. For the Belgian and the Netherland’s registry, patients 
with a tumor located in the lower and middle third of the 
rectum were enrolled. In our study, we included patients with 
primary adenocarcinoma of the rectum between 0 and 15 cm 
above the anal verge. 
In our study, the overall rate of postoperative complica-
tions was higher in medium volume centers compared to high 
and low volume centers. Jonker et al [7] reported similar ob-
servations, although the overall complication rate was higher 
than in our study. The low rate of defunctioning stoma in LAR 
(5–31% depending on the volume of the center) reported in 
our study is surprising because the data from the Netherlands 
show a significantly higher percentage of anastomosis with 
a defunctioning stoma (65.5–80.3% depending on the hospi-
tal volume) [7]. Despite this, the rate of anastomotic leakage 
in PSSO-01 was similar to the population-based data of the 
DSCA [10]. These outcomes confirm the observations that 
a high tendency towards defunctioning stoma construction 
did not result in lower overall anastomotic leakage and the 
ability to select patients for stoma construction plays the most 
important role in the choice of optimal surgical strategy [10]. 
The long-term outcomes of the present study showed 
a high rate (63%) of persistent stoma over the 1 year follow-
-up. After excluding the surgical procedures connected with 
permanent end-colostomy, we conclude that most of curative 
HRTM is a definitive surgical procedure and almost half of the 
defunctioning stomas are not closed following 12 months. The 
reasons for leaving the protective stoma allow us to assume 
that most of them will remain permanently. Data from DSCA 
has shown 54.2% end-colostomy procedures (included ASR) 
[2]. It is higher than in our study (43%). European multi-center 
studies present data that most diverting stoma is reversed 
within 12 months, but that one in four defunctioning stomas is 
not reversed 3 years after surgery [11–13]. Anastomotic leakage 
is one of the most important risk factors for not reversing sto-
mas. A Swedish retrospective multi-center study [14] including 
1442 patients undergoing anterior resection observed that the 
overall rate of permanent stoma among patients with anasto-
motic leakage was 65%. The rate of definitive stoma at a level 
of >60% following 12 months in our study seems to be high. 
However, other studies showed similar results. In a retrospec-
tive study conducted in Sweden, the permanent stoma rate 
was 63.2% when emergency and palliative procedures were 
included, and 54.9% when only elective curative cases were 
considered. The authors concluded that stoma rates taken at 
face value may not provide an accurate picture of a particular 
colorectal unit’s quality of care [15]. 
Conclusions
We are presenting the results obtained in the prospective 
multi-center study PSSO-01, which focused on the surgical tre-
atment of rectal cancer. We compared our outcomes with Eu-
ropean population-based studies. Finally, the question should 
be asked: are these results representative of the population of 
rectal cancer patients undergoing surgery in Poland? Although 
the study had a prospective nature, it has several important 
limitations. Firstly, there was the administrative burden associa-
ted with data collection. There was no monitoring of the quality 
of recorded data at each of the centers by an independent 
study office. The accurate measurement of quality of care is 
complex and requires the collection of multiple data points 
from different phases of the care process. Therefore, the dataset 
is limited, but still entails valid information. Secondly, PSSO-01 
has a limitation regarding the possibility of selection bias since 
the participation of the centers in the study was voluntary. 
Nevertheless, different volume centers were represented in 
this study. Unfortunately, in comparison to data from European 
population-based studies, the proportion of high, medium, 
and low centers in PSSO-01 underrepresented low volume 
centers. However, the results reported by the high and medium 
volume centers may correspond to the actual situation. 
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